9UY-11096-40061
3 vaccinations
3 coded responses
39 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 212 / MD
- Registered
- 2021-07-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
FU8-12826-40922
Child or adolescent in my care · Female · 2022-06-23
32L-14320-69422
Child or adolescent in my care · Male · 2022-06-23
Timeline
-
2021-07-30
Registered in v-safe
-
2021-07-30
Dose 1 — Pfizer-BioNTech
- 2021-07-30
- 2021-07-31
- 2021-08-01
- 2021-08-02
- 2021-08-03
- 2021-08-04
- 2021-08-05
- 2021-08-06
- 2021-08-13
-
2021-08-20
Dose 2 — Pfizer-BioNTech
- 2021-08-20
-
2021-08-21
Survey response — days 1–6 daily, dose 2MedDRA: Abnormal dreams — Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Intense dreamsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-08-23
- 2021-08-24
- 2021-08-25
- 2021-08-26
- 2021-08-27
- 2021-09-03
- 2021-09-10
- 2021-09-17
- 2021-09-24
- 2021-10-01
- 2021-11-19
-
2022-01-21
Dose 3 — Moderna
- 2022-01-21
-
2022-01-22
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · NoneAdult check-in
- 2022-01-24
- 2022-01-25
- 2022-01-26
- 2022-01-27
- 2022-01-28
- 2022-02-04
- 2022-02-11
- 2022-02-18
- 2022-02-25
-
2022-03-04
Survey response — day 42, dose 3MedDRA: Nasopharyngitis — Feeling: GoodFree text: ColdMedDRA releases: 2024-11 · check-in free text available
- 2022-04-22
- 2022-07-22
-
2023-01-21
Survey response — 12 months, dose 3MedDRA: COVID-19, Cough, Dyspnoea, Pain, Pyrexia — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-01-21
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2023-01-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-30 | Pfizer-BioNTech | No |
| 2 | 2021-08-20 | Pfizer-BioNTech | No |
| 3 | 2022-01-21 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Intense dreams
Release 11 — day 42, dose 3
Symptoms: Cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Abnormal dreams | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release